SCHEMBL2476913

SCHEMBL2476913

Cc1ccc(C2c3c(C)c(N4CCN(Cc5ccc(F)cc5)CC4)c(C)c(C)c3OC2(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
KDM4E B2RXH2 3/20 0.37
MCHR1 Q99705 1/20 0.37
MAPK1 P28482 2/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HTT P42858 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR1A P08908 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2473366 0.99 MAPT (0.37) MAPTKDM4EMCHR1MAPK1ALDH1A1
Hydrochloric Acid SCHEMBL2471300 0.89 LMNA (0.45) MAPTKDM4EMAPK1ALDH1A1LMNA
SCHEMBL2475248 0.89 POLB (0.41) MAPTMCHR1POLBMEN1KMT2A
Hydrochloric Acid SCHEMBL2471726 0.88 POLB (0.40) MAPTMCHR1POLBMEN1KMT2A
SCHEMBL2474052 0.87 CCR4 (0.34) MAPTMAPK1ALDH1A1LMNAMEN1
SCHEMBL2468274 0.84 NPC1 (0.36) MAPTMAPK1ALDH1A1
Hydrochloric Acid SCHEMBL2471488 0.82 KDM4E (0.41) KDM4EALDH1A1POLBDRD2DRD4
SCHEMBL2474570 0.82 SIGMAR1 (0.45) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL14492173 0.81 ALDH1A1 (0.39) MAPTKDM4EMCHR1MAPK1ALDH1A1
SCHEMBL2477456 0.81 KMT2A (0.43) MAPTKDM4EALDH1A1LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411052-B1 BENZO-FUSED 5-MEMBERED HETROCYCLE COMPOUNDS,PROCESS FOR PREPARATION OF THE SAME, AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2011-10-05 EP claimed
US-20070149558-A1 Benzo-fused 5-membered heterocyclic compounds, their production and use OHKAWA SHIGENORI 2007-06-28 US disclosed
US-20070149558-A1 Benzo-fused 5-membered heterocyclic compounds, their production and use OHKAWA SHIGENORI 2007-06-28 US disclosed
US-7208495-B2 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149558-A1 Benzo-fused 5-membered heterocyclic compounds, their production and use CBR1, DBH, PARK7 MAPT 494/4885KDM4E 1841/4885MCHR1 495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.